STAT+: Amid Aduhelm woes, Biogen moves to pare back office space
Biogen is moving to scale back its real estate footprint in Kendall Square and in Weston, as the Cambridge-based biotech company aims to cut $1 billion in costs in the wake of a disastrous rollout of its Alzheimer’s drug Aduhelm.
Biogen is looking to sublease more than 183,000 square feet at 300 Binney St. in Cambridge — across the street from its headquarters — and is also subleasing two floors, or 80,000 square feet, at one of its two properties at 133 Boston Pond Road in Weston.
Continue to STAT+ to read the full story…
Read Original Article: STAT+: Amid Aduhelm woes, Biogen moves to pare back office space »
